Methotrexate Plus Leflunomide Proves Effective for PsA

The combination therapy outperformed methotrexate monotherapy as a treatment option for patients with psoriatic arthritis (PsA), though it did come with an increase in side effects.

Related Keywords

California ,United States ,San Diego ,Netherlands ,Spain ,Nijmegen ,Gelderland ,Dutch ,Arthur Kavanaugh ,Michellelm Mulder ,University Of California ,European Alliance Of Associations ,Department Of Rheumatology At Sint Maartenskliniek ,University Of Cordoba Spain ,Group For Research ,Sint Maartenskliniek ,Psoriatic Arthritis ,European Alliance ,Psoriatic Arthritis Disease Activity Score ,Medscape Medical News ,Turns Perception ,Combination Therapy Into Reality ,Forgotten No Longer ,Innovative Therapy ,Medscape Medical ,Psoriasis ,Prostate Carcinoma ,Alignant Prostate Neoplasm ,Prostate Cancer ,Ancer Prostate ,Prostate Specific Antigen Psa ,Prostate Specific Antigen ,Sa ,Activism ,Activist ,Social Issues ,Adverse Effects ,Side Effects ,Patient Safety ,Treatment Guidelines ,